FindTrial
Sign In

Nasopharyngeal Laryngoscopy

PROCEDURE2 trials

Sponsors

Mayo Clinic, Northwestern University

Conditions

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal CarcinomaClinical Stage III HPV-Mediated (p16-pos) Oropharyngeal CarcinomaClinical Stage IV HPV-Mediated (p16-pos)Oropharyngeal CarcinomaHead and Neck CarcinomaStage II Hypopharyngeal Carcinoma AJCC v8Stage II Laryngeal Cancer AJCC v8

Phase 2

Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial
Not yet recruitingNCT07178301
Northwestern UniversityClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Start: 2026-03-20End: 2031-03-20Target: 100Updated: 2025-09-17

Unknown Phase

A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation
WithdrawnNCT05512767
Mayo ClinicClinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage III HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage IV HPV-Mediated (p16-pos)Oropharyngeal Carcinoma +13
Start: 2022-12-01End: 2024-08-22Updated: 2023-01-06